Furthermore, a significant interaction effect between BRCA2 PV status and PGS on cancer risk was observed for two cancers: female breast cancer (pinteraction < 0.001) and prostate cancer (pinteraction = 0.04). This evidence concerns the gene BRCA2 and Familial prostate cancer.